£30m Study Paves the Way for New Treatments for People with Cirrhosis
£30M Study Paves the Way for New Treatments for People with Cirrhosis

The most extensive clinical study into liver cirrhosis ever conducted worldwide has been announced by Newcastle University, University of Edinburgh and leading research-driven global biopharmaceutical company, Boehringer Ingelheim. The ADVANCE (Accelerating Discovery:…